PURPOSE: With the initiation of human hyperpolarized 13 C (HP-13 C) trials at multiple sites and the development of improved acquisition methods, there is an imminent need to maximally extract diagnostic information to facilitate clinical interpretation. This study aims to improve human HP-13 C MR spectroscopic imaging through means of Tensor Rank truncation-Image enhancement (TRI) and optimal receiver combination (ORC). METHODS: A data-driven processing framework for dynamic HP 13 C MR spectroscopic imaging (MRSI) was developed. Using patient data sets acquired with both multichannel arrays and single-element receivers from the brain, abdomen, and pelvis, we examined the theory and application of TRI, as well as 2 ORC techniques: whitened singular value decomposition (WSVD) and first-point phasing. Optimal conditions for TRI were derived based on bias-variance trade-off. RESULTS: TRI and ORC techniques together provided a 63-fold mean apparent signal-to-noise ratio (aSNR) gain for receiver arrays and a 31-fold gain for single-element configurations, which particularly improved quantification of the lower-SNR-[13 C]bicarbonate and [1-13 C]alanine signals that were otherwise not detectable in many cases. Substantial SNR enhancements were observed for data sets that were acquired even with suboptimal experimental conditions, including delayed (114 s) injection (8× aSNR gain solely by TRI), or from challenging anatomy or geometry, as in the case of a pediatric patient with brainstem tumor (597× using combined TRI and WSVD). Improved correlation between elevated pyruvate-to-lactate conversion, biopsy-confirmed cancer, and mp-MRI lesions demonstrated that TRI recovered quantitative diagnostic information. CONCLUSION: Overall, this combined approach was effective across imaging targets and receiver configurations and could greatly benefit ongoing and future HP 13 C MRI research through major aSNR improvements.
PURPOSE: With the initiation of human hyperpolarized 13 C (HP-13 C) trials at multiple sites and the development of improved acquisition methods, there is an imminent need to maximally extract diagnostic information to facilitate clinical interpretation. This study aims to improve human HP-13 C MR spectroscopic imaging through means of Tensor Rank truncation-Image enhancement (TRI) and optimal receiver combination (ORC). METHODS: A data-driven processing framework for dynamic HP 13 C MR spectroscopic imaging (MRSI) was developed. Using patient data sets acquired with both multichannel arrays and single-element receivers from the brain, abdomen, and pelvis, we examined the theory and application of TRI, as well as 2 ORC techniques: whitened singular value decomposition (WSVD) and first-point phasing. Optimal conditions for TRI were derived based on bias-variance trade-off. RESULTS:TRI and ORC techniques together provided a 63-fold mean apparent signal-to-noise ratio (aSNR) gain for receiver arrays and a 31-fold gain for single-element configurations, which particularly improved quantification of the lower-SNR-[13 C]bicarbonate and [1-13 C]alanine signals that were otherwise not detectable in many cases. Substantial SNR enhancements were observed for data sets that were acquired even with suboptimal experimental conditions, including delayed (114 s) injection (8× aSNR gain solely by TRI), or from challenging anatomy or geometry, as in the case of a pediatric patient with brainstem tumor (597× using combined TRI and WSVD). Improved correlation between elevated pyruvate-to-lactate conversion, biopsy-confirmed cancer, and mp-MRI lesions demonstrated that TRI recovered quantitative diagnostic information. CONCLUSION: Overall, this combined approach was effective across imaging targets and receiver configurations and could greatly benefit ongoing and future HP 13 C MRI research through major aSNR improvements.
Authors: Yan Liu; Chao Ma; Bryan A Clifford; Fan Lam; Curtis L Johnson; Zhi-Pei Liang Journal: IEEE Trans Biomed Eng Date: 2015-09-03 Impact factor: 4.538
Authors: Adam W Autry; Jeremy W Gordon; Lucas Carvajal; Azma Mareyam; Hsin-Yu Chen; Ilwoo Park; Daniele Mammoli; Maryam Vareth; Susan M Chang; Lawrence L Wald; Duan Xu; Daniel B Vigneron; Sarah J Nelson; Yan Li Journal: Magn Reson Med Date: 2019-03-29 Impact factor: 4.668
Authors: Daniele Mammoli; Jeremy Gordon; Adam Autry; Peder E Z Larson; Yan Li; Hsin-Yu Chen; Brian Chung; Peter Shin; Mark Van Criekinge; Lucas Carvajal; James B Slater; Robert Bok; Jason Crane; Duan Xu; Susan Chang; Daniel B Vigneron Journal: IEEE Trans Med Imaging Date: 2019-07-02 Impact factor: 10.048
Authors: Peder E Z Larson; Simon Hu; Michael Lustig; Adam B Kerr; Sarah J Nelson; John Kurhanewicz; John M Pauly; Daniel B Vigneron Journal: Magn Reson Med Date: 2010-10-11 Impact factor: 4.668
Authors: Jeffrey R Brender; Shun Kishimoto; Hellmut Merkle; Galen Reed; Ralph E Hurd; Albert P Chen; Jan Henrik Ardenkjaer-Larsen; Jeeva Munasinghe; Keita Saito; Tomohiro Seki; Nobu Oshima; Kazutoshi Yamamoto; Peter L Choyke; James Mitchell; Murali C Krishna Journal: Sci Rep Date: 2019-03-04 Impact factor: 4.379
Authors: Donghyun Hong; Georgios Batsios; Pavithra Viswanath; Anne Marie Gillespie; Manushka Vaidya; Peder E Z Larson; Sabrina M Ronen Journal: Magn Reson Med Date: 2021-11-14 Impact factor: 4.668
Authors: Jasmine Y Hu; Yaewon Kim; Adam W Autry; Mary M Frost; Robert A Bok; Javier E Villanueva-Meyer; Duan Xu; Yan Li; Peder E Z Larson; Daniel B Vigneron; Jeremy W Gordon Journal: Magn Reson Med Date: 2022-06-26 Impact factor: 3.737
Authors: A W Autry; I Park; C Kline; H-Y Chen; J W Gordon; S Raber; C Hoffman; Y Kim; K Okamoto; D B Vigneron; J M Lupo; M Prados; Y Li; D Xu; S Mueller Journal: AJNR Am J Neuroradiol Date: 2020-12-03 Impact factor: 3.825
Authors: Cornelius von Morze; John A Engelbach; Tyler Blazey; James D Quirk; Galen D Reed; Joseph E Ippolito; Joel R Garbow Journal: Magn Reson Med Date: 2020-11-28 Impact factor: 4.668
Authors: Stephan Ursprung; Ramona Woitek; Mary A McLean; Andrew N Priest; Mireia Crispin-Ortuzar; Cara R Brodie; Andrew B Gill; Marcel Gehrung; Lucian Beer; Antony C P Riddick; Johanna Field-Rayner; James T Grist; Surrin S Deen; Frank Riemer; Joshua D Kaggie; Fulvio Zaccagna; Joao A G Duarte; Matthew J Locke; Amy Frary; Tevita F Aho; James N Armitage; Ruth Casey; Iosif A Mendichovszky; Sarah J Welsh; Tristan Barrett; Martin J Graves; Tim Eisen; Thomas J Mitchell; Anne Y Warren; Kevin M Brindle; Evis Sala; Grant D Stewart; Ferdia A Gallagher Journal: Cancers (Basel) Date: 2022-01-11 Impact factor: 6.575
Authors: Caitlin V McCowan; Duncan Salmon; Jingzhe Hu; Shivanand Pudakalakatti; Nicholas Whiting; Jennifer S Davis; Daniel D Carson; Niki M Zacharias; Pratip K Bhattacharya; Mary C Farach-Carson Journal: Diagnostics (Basel) Date: 2022-03-01